Free Trial

PetVivo Q3 2023 Earnings Report

PetVivo logo
$0.58 +0.01 (+1.74%)
(As of 12/26/2024 05:38 PM ET)

PetVivo Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
PetVivo Holdings Inc Price / Book
Q2 2025 PetVivo Holdings Inc Earnings Call
PetVivo Holdings, Inc.: PetVivo Reports Fiscal Q2 2025 Results
See More PetVivo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetVivo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetVivo and other key companies, straight to your email.

About PetVivo

PetVivo (NASDAQ:PETV), a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

View PetVivo Profile

More Earnings Resources from MarketBeat